skip to main content

Research areas

Each component of the Texas A&M University Health Science Center has a research office that is responsible for local administration of its research programs and an associate dean (or equivalent) who reports to the Vice President for Research. Each component also has a number of signature research programs and priorities.

College of
Dentistry

Larry Bellinger, PhD
Associate Dean for Advanced Education
214.828.8322
lbellinger@tamhsc.edu

Signature programs and priorities:

  • Tooth development and genetics
  • Dentin, bone and cartilage matrix biology
  • Temporomandibular joint function, dysfunction and pain
  • Implants, bone regeneration devices and devices to move teeth
  • Stem cell applications for regenerative strategies and scaffold design
  • Use of biomarkers to detect oral cancer

College of
Medicine

Van Wilson, PhD
Vice Dean for Research and Graduate Studies
979.436.0310
wilson@medicine.tamhsc.edu

Signature programs and priorities:

  • Neuroscience: Post-Traumatic Stress Disorder/Traumatic Brain Injury, development, female specific issues and degenerative diseases
  • Infectious disease: host responses to infection, vaccines/diagnostics and animal models of human infectious disease
  • Physiological and regenerative medicine: stem cells, hepatic disease and cardiovascular disease

College of
Nursing

Regina Bentley, EdD, MSN, RN, CNE
Interim Dean
979.436.0112
bentley@tamhsc.edu

Signature programs and priorities:

  • Forensic nursing
  • Hispanic populations
  • Childhood obesity
  • Public health nursing
  • Chronic diseases
  • Vulnerable populations

Irma Lerma Rangel
College of Pharmacy

Mansoor Khan, PhD
Professor
Vice Dean of College Station Campus
Interim Department Head of Pharmaceutical Sciences
979.436.0561
mkhan@tamhsc.edu

Signature programs and priorities:

  • Drug Delivery and formulations, including nanoparticulates
  • Pharmacokinetics and bioequivalence studies
  • Support for Investigational New Drugs (INDs), New Drug Applications (NDAs), Abbreviated New Drug Applications (ANDAs for generic products)
  • Use pharmacological and genetic approaches to inform on biology
  • Integrate engineering, biological, medicinal chemistry and formulation/delivery in drug discovery programs focused on defined diseases where we have existing strengths
  • Establish an integrated research facility for drug discovery, development and delivery, underpinned by a pharmaceutical focus in pharmacology, integrative biology, immunology and microbiology
  • Drug repositioning
  • Pediatric products
  • Post marketing product evaluations

School of
Public Health

Marcia Ory, PhD, MPH
Associate Director for Research
979.436.9368
mory@sph.tamhsc.edu

Signature programs and priorities:

  • Prevention research
  • Healthy aging through long-term care issues
  • Environmental exposures and adverse pregnancy outcomes

Institute of
Biosciences and Technology

Peter J. A. Davies, MD, PhD
Associate Director
713.677.7473
pdavies@ibt.tamhsc.edu

Signature programs and priorities:

  • Cancer and stem cell biology
  • Environmental and genetic medicine
  • Infectious and inflammatory diseases
  • Translational cancer research